Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale GRAMMER ELIZABETH A sold 5,992 shares at $4.08 ($24,456)
  2. 4 Open-market sale Chief Commercial Officer sold 2,507 shares at $4.08 ($10,232)
  3. 4 Open-market buy Director bought 100,000 shares at $3.29 ($329,120)
  4. 4 Grant or award Director acquired 42,056 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 381,377 shares at $4.22 ($1,610,936)
  7. 4 Planned sale President & CEO sold 41,666 shares at $4.25 ($177,168)
  8. 4 Planned sale President & CEO sold 41,666 shares at $4.59 ($191,151)
  9. 4 Planned sale President & CEO sold 41,668 shares at $5.36 ($223,199)
  10. 4 Grant or award Chief Medical Officer acquired 105,200 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 136,680 shares (grant or award)
  12. 4 Grant or award President & CEO acquired 570,217 shares (grant or award)
  13. 4 Grant or award Kelliher Mike acquired 136,680 shares (grant or award)
  14. 4 Grant or award GRAMMER ELIZABETH A acquired 136,680 shares (grant or award)
  15. 4 Grant or award Chief Commercial Officer acquired 136,680 shares (grant or award)
  16. 4 Open-market buy Director bought 77,729 shares at $5.00 ($388,738)
  17. 4 Open-market sale Chief Medical Officer sold 4,941 shares at $5.62 ($27,783)
  18. 4 Open-market sale Chief Financial Officer sold 5,171 shares at $5.62 ($29,077)
  19. 4 Open-market sale President & CEO sold 22,964 shares at $5.62 ($129,124)
  20. 4 Open-market sale GRAMMER ELIZABETH A sold 4,291 shares at $5.62 ($24,128)

Page 5 of 35 · 690 filings